DE HB273

Replaces the specific list of 22 synthetic cannabinoid compounds in Schedule I with broader structural class definitions to cover current and future synthetic cannabinoids.

Defines synthetic cannabinoids as any non-FDA-approved chemically synthesized material that produces a psychotropic response by binding to cannabinoid receptors.

Establishes eight structural cannabinoid classes including naphthoylindoles, naphthylmethylindoles, naphthoylpyrroles, naphthylmethylindenes, phenylacetylindoles, cyclohexylphenols, benzoylindoles, and adamantoylindoles.

Requires a two-thirds majority vote in both houses of the General Assembly due to constitutional requirements for establishing jurisdiction over inferior courts for controlled substance possession misdemeanors.